Key Contacts

contact details for our global offices
email: info@orb.group
UK: +44 203 519 2229
USA: +1 650 252 0002
Sweden: +46 852 500 200
Turkey: +90 212 705 5468
UAE: +971 509 385 718

Recent News

Latest Tweets

BRID – Alzeihmer Treatment

ORB Group > BRID – Alzeihmer Treatment
Alzeihmer treatment (BRID)
Not as much as 10 years ago, scarcely anybody could have anticipated that endeavours to assemble coordinate utilitarian interfaces amongst brains and artificial devices, for example, PCs and mechanical appendages, would have succeeded so promptly, and in the process would have prompted the foundation of another range of frameworks within neuroscience. Conceived as a profoundly multidisciplinary field, fundamental research on brain–machine interfaces (BMIs) has moved at a shocking pace.
Alzheimer & traumatic brain injury treatment programme involves, BRID capable of recording brain signals and transmitting the recorded signal back to hippocampus by decoding and encoding neurological signals into digital signals with effective data rate of ~40 gigabits per second which is wirelessly controlled by artificial intelligence for real time analysis and decoding of neural signals. The very same technology could also be used to develop smart prosthetics and nerve coupling that could potentially lead to the production of artificial appendages as dexterous as natural ones as well as bring back mobility to paraplegic patients.
Simply the memories are stored in the hypercloud controlled by AI and could be accessed by the patients with memory loss once required.
Research steps
  • Development of multi-scale computational models for coding and decoding of neural activities by development of multi-scale computational models with high spatial and temporal resolution that describe how neurons, code declarative memories and new methods for analysis and decoding of neural signals to understand how targeted stimulation might be applied.

  • Integrate the computational models developed into new, implantable, closed-loop systems able to deliver targeted neural stimulation that ultimately help restore memory function.

  • Animal studies to advance the state-of-the-art of quantitative models that account for the encoding and retrieval of complex memories and memory attributes, including their hierarchical associations with one another.

  • Clinical studies involving volunteers living with deficits in the encoding and/or retrieval of declarative memories.

Market Study
The global cost of Alzheimer’s is estimated to be $605 billion, which is equivalent to 1% of the entire world’s gross domestic product.
Brand name
Patients population
Market (billions)
BRID for Alzheimer
46 million
$92
BRID for traumatic brain injury
54 million
$108
WordPress Themes